Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,819 | N/A | N/A | -26,950 | -36,530 |
| Depreciation Amortization | 155 | N/A | N/A | 3,140 | 6,430 |
| Income taxes - deferred | -94 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 722 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,868 | N/A | N/A | 20,220 | -23,820 |
| Other Operating Activity | -54 | 0 | 0 | 6,180 | 14,370 |
| Operating Cash Flow | $-66,222 | $N/A | $N/A | $2,590 | $-39,550 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,956 | N/A | N/A | N/A | N/A |
| PPE Investments | -900 | N/A | N/A | -1,810 | -2,690 |
| Other Investing Activity | 0 | 0 | 0 | -17,780 | 53,400 |
| Investing Cash Flow | $-3,856 | $N/A | $N/A | $-19,590 | $50,710 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 58 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 26 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -22 | 0 | 0 | 3,110 | 1,550 |
| Financing Cash Flow | $62 | $N/A | $N/A | $3,110 | $1,550 |
| Exchange Rate Effect | -131 | N/A | N/A | -460 | 300 |
| Beginning Cash Position | 82,522 | N/A | N/A | 43,210 | 30,180 |
| End Cash Position | 12,375 | N/A | N/A | 28,860 | 43,210 |
| Net Cash Flow | $-70,147 | $N/A | $N/A | $-14,350 | $13,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,222 | N/A | N/A | 2,590 | -39,550 |
| Capital Expenditure | -900 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -67,122 | 0 | 0 | 2,590 | -39,550 |